Sodium Ascorbate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14482 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | osteoarthritis | KG + DL |
| 3 | enterocolitis (disease) | KG + DL |
| 4 | pseudoachondroplasia | KG + DL |
| 5 | osteoarthritis susceptibility | KG + DL |
| 6 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 7 | brachyolmia | KG + DL |
| 8 | exercise-induced malignant hyperthermia | KG + DL |
| 9 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 10 | myosclerosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.